BackAutolus Therapeutics plc Overview

Autolus Therapeutics plc Total Assets

Track Autolus Therapeutics plc's total assets ($490M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$493.23M
↓ 31.59% YoYΔ $-227.75M vs prior year quarter

Peer trimmed avg / median

Loading

Autolus Therapeutics plc Total Assets History

Loading

Autolus Therapeutics plc vs. peers: Total Assets Comparison

Loading

Autolus Therapeutics plc Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Autolus Therapeutics plc (AUTL) FAQ

Autolus Therapeutics plc (AUTL) currently reports a total assets of $490M as of June 2026. That compares with $720M in the prior-year period — down 31.6% year over year. Use the charts on this page to explore Autolus Therapeutics plc's total assets history and peer comparisons.

Autolus Therapeutics plc's total assets decreased from $720M to $490M — a 31.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Autolus Therapeutics plc reported $490M in total assets as of June 2026. That compares with $720M in the prior-year period — down 31.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $490M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Autolus Therapeutics plc, and consider following AUTL for alerts when major investors trade the stock.

Autolus Therapeutics plc is classified in the Healthcare sector. On total assets, it currently shows $490M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AUTL with unrelated industries.